Recent data demonstrate that BACH2 downregulation in normal lymphocytes increases age-related resistance to apoptosis and these alterations were even more pronounced in the T and B cells from CLL patients [54]. Here, BACH2 is linked to B-cell chronic lymphocytic leukemia.